A portable device for accurate hemoglobin A1C testing
Official title: Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing
Funded at Hemex Health, INC. · NIH-10656550 · Data updated 2026-11-12
This study is working on a small, easy-to-use device called HemeChip that can quickly and affordably check hemoglobin A1C levels for people with diabetes, especially in places where healthcare is hard to reach, so they can better manage their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hemex Health, INC. NIH-funded |
| Lab location | 1 site (Portland, UNITED STATES) |
| Project start | August 20, 2018 |
| Project end | June 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $865,222 |
| NIH project number | 5R42DK119048-03 |
| Project ID | NIH-10656550 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with diabetes, particularly in low and middle-income countries where access to reliable testing is limited.
✕Less likely to help
Patients who do not have diabetes or prediabetes may not receive any benefit from this research.
What this research studies
This research focuses on developing a portable and affordable microchip electrophoresis system for testing hemoglobin A1C levels, which is crucial for managing diabetes. The device, known as HemeChip, aims to provide accurate results even in areas with limited access to healthcare facilities. By improving the reliability of A1C testing, especially in low and middle-income countries, the research seeks to enhance diabetes management and patient outcomes. The approach involves using advanced technology to ensure that patients can receive timely and precise testing without the need for expensive laboratory services.
Why it matters
Potential benefit: If successful, this research could significantly improve diabetes management by providing accessible and accurate hemoglobin A1C testing.
How similar studies have gone: Other research has shown success with portable diagnostic devices, indicating a promising potential for this novel approach.
Where this research is happening
-
Hemex Health, INC.
Portland, United States Active
Researchers
- Principal investigator: Galen, Peter — Hemex Health, INC.
- Study coordinator: Galen, Peter
Related research
Other NIH-funded projects on the same topics.
-
Affordable microchip technology for blood testing in sickle cell disease and anemia
This study is working on a new, affordable device that can quickly test your blood for sickle cell disease and other types of anemia right at your doctor's office, helping you and your healthcare team get important results faster for better care.
-
A new test for measuring how hemoglobin releases oxygen in sickle cell disease.
This study is working on a quick and easy test that helps people with sickle cell disease check how well their blood can carry oxygen, which could lead to better treatment and care, especially in places where medical resources are limited.
-
Using a special system to assess brain injuries in patients
This study is testing a new way to help doctors quickly and accurately identify mild traumatic brain injuries using a special system and blood tests, which could be especially helpful in emergency rooms that don’t have advanced equipment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.